UnknownNCT01084850
Corneal Endothelium Morphology and Central Thickness in Type II Diabetes Mellitus and Normal Subjects
Studying Congenital hereditary endothelial dystrophy type II
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Frederiksberg University Hospital
- Principal Investigator
- Jens C Norregaard, MD, phdFrederiksberg University Hospital, Eye Clinque
- Enrollment
- 300 enrolled
- Eligibility
- All sexes
- Timeline
- 2009 – 2010
Study locations (1)
- Frederiksberg University Eye Clinque, Frederiksberg, Frederiksberg, Denmark
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01084850 on ClinicalTrials.govOther trials for Congenital hereditary endothelial dystrophy type II
Additional recruiting or active studies for the same condition.
See all trials for Congenital hereditary endothelial dystrophy type II →